Minaxi Jhawer
Montefiore Medical Center
USA
Name/email consistency: high
- Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinoma. Jhawer, M., Rosen, L., Dancey, J., Hochster, H., Hamburg, S., Tempero, M., Clendeninn, N., Mani, S. Invest. New. Drugs (2007)